DrugPatentWatch Database Preview
Casi Pharms Inc Company Profile
What is the competitive landscape for CASI PHARMS INC, and what generic and branded alternatives to CASI PHARMS INC drugs are available?
CASI PHARMS INC has twenty-six approved drugs.
Summary for Casi Pharms Inc
| US Patents: | 0 |
| Tradenames: | 24 |
| Ingredients: | 24 |
| NDAs: | 26 |
Drugs and US Patents for Casi Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Casi Pharms Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077310-001 | Nov 8, 2005 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Casi Pharms Inc | EPINASTINE HYDROCHLORIDE | epinastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 203384-001 | Dec 7, 2016 | DISCN | No | No | Start Trial | Start Trial | |||||
| Casi Pharms Inc | TIZANIDINE HYDROCHLORIDE | tizanidine hydrochloride | TABLET;ORAL | 076280-002 | Jun 27, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Casi Pharms Inc | LISINOPRIL | lisinopril | TABLET;ORAL | 075994-006 | Jul 1, 2002 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Casi Pharms Inc | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 076514-003 | Jul 2, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Casi Pharms Inc | REPAGLINIDE | repaglinide | TABLET;ORAL | 078555-003 | Jan 22, 2014 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
